Study of the Influence of the Mediterranean Diet on the Quality of Life of Patients With Endometriosis.
- Sponsor
- Biogipuzkoa Health Research Institute
- Study ID
- NCT07270393
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Diet supplementation — OTHERThe severities of chronic disease symptoms correlate with the levels of analytical parameters of inflammation. Studies have been published in which the Mediterranean diet has an anti-inflammatory phenomenon, decreasing inflammation parameters. This decrease correlates with an improvement in symptoms . Endometriosis is a chronic inflammatory disease and the influence of the Mediterranean diet on the decrease of inflammation parameters in women with endometriosis has been studied.
Study Details
The severities of chronic disease symptoms correlate with the levels of analytical parameters of inflammation. Studies have been published in which the Mediterranean diet has an anti-inflammatory phenomenon, decreasing inflammation parameters. This decrease correlates with an improvement in symptoms. Endometriosis is a chronic inflammatory disease and the influence of the Mediterranean diet on the decrease of inflammation parameters in women with endometriosis has been studied. The studies carried out to assess whether this decrease in inflammatory parameters correlates with clinical improvement and quality of life in these patients have low/very low scientific evidence (small sample size, no control group) and with different interventions (diets, restrictions and/or supplements), which prevent their analysis as a whole. Therefore, our hypothesis is that the Mediterranean diet, due to its anti-inflammatory effect, can improve the symptomatology and quality of life of patients with endometriosis.
Key Dates
- First listed
- Dec 8, 2025
- Start date
- Dec 1, 2025
- Status verified
- Mar 2025
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 104 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- No Intervention: Control GroupThis group will not receive normocaloric Mediterranean diet recommendations.
- Experimental: Intervention GroupThis group will receive a series of normocaloric Mediterranean diet recommendations.
Primary Outcome Measure
Quality of life and endometriosis. [ Time Frame: 24 weeks ]
Central Contacts
- Jone Paredes Goenaga [email protected], Ginecology and Obstetrics943007478
Find similar trials
Related Studies
- Cardiovascular Disease Risk in Women With EndometriosisEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Endometriosis and Microvascular Dysfunction; Simvastatin and DuaveePHASE4 · Recruiting · Penn State University · New Haven, Connecticut
- Endometriosis and Microvascular Dysfunction: Role of InflammationEARLY_PHASE1 · Recruiting · Penn State University · University Park, Pennsylvania